Spermosens AB
STO: SPERM.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Tore Duvold
- Employees
- 3
- Headquarters
- Lund, Sweden
- IPO year
- 2021
- Market cap
- SEK 33.0M
- Website
- https://www.spermosens.com
Loading SPERM…
Loading profile data…Frequently asked questions about SPERM
What does Spermosens AB (SPERM.ST) do?
Spermosens AB engages in the research, development, and commercialization of diagnostic technology in health and medical care in Sweden. The company provides male infertility fertility diagnostics and fertility treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individ...
Where does SPERM.ST trade?
Spermosens AB (SPERM.ST) trades on the Stockholm Stock Exchange.
What sector is SPERM.ST in?
Spermosens AB (SPERM.ST) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Spermosens AB?
Tore Duvold is the chief executive officer of Spermosens AB (SPERM.ST).
Where is Spermosens AB headquartered?
Spermosens AB is headquartered in Sweden.
Does SPERM.ST pay a dividend?
Spermosens AB (SPERM.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SPERM.ST go public?
Spermosens AB (SPERM.ST) completed its initial public offering in 2021.